Unspecified PARP inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified PARP inhibitor, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations [Phase 2]